Millennium Management’s Abeona Therapeutics ABEO Stock Holding History

Millennium Management’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-100,000	Closed	-$424K	–	6033
2024 Q2	$424K	Buy	100,000 +70,000	+233%	+$357K	﹤0.01%	4695
2024 Q1	$218K	Buy	+30,000	New	+$190K	﹤0.01%	5332
2023 Q4	–	Sell	-42,900	Closed	-$181K	–	6008
2023 Q3	$181K	Sell	42,900 -3,100	-7%	-$11.7K	﹤0.01%	5164
2023 Q2	$185K	Buy	+46,000	New	+$161K	﹤0.01%	5147
2020 Q1	–	Sell	-12,912	Closed	-$1.06M	–	3774
2019 Q4	$1.06M	Buy	12,912 +2,912	+29%	+$205K	﹤0.01%	2979
2019 Q3	$565K	Buy	+10,000	New	+$749K	﹤0.01%	3186

Other funds holding ABEO

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management's ABEO Position: Q1 2026 in Review

Millennium Management increased its Abeona Therapeutics (ABEO) stake by 24% in Q1 2026, buying an estimated $409K and bringing the position to 425,426 shares worth $1.91M. The position accounts for ﹤0.01% of the portfolio, ranked #3914.

Millennium Management first reported a position in ABEO in Q1 2015 and has held it in 40 quarters since. The position peaked at $16.5M in Q2 2019. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

Millennium Management held 425,426 shares of Abeona Therapeutics worth $1.91M as of Q1 2026.
Millennium Management bought 81,858 Abeona Therapeutics shares in Q1 2026, an estimated $409K.
Abeona Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3914 holding.
Millennium Management first reported a position in Abeona Therapeutics in Q1 2015 and has held it in 40 quarters since.
Millennium Management's Abeona Therapeutics position peaked at $16.5M in Q2 2019.
108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.